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Abstract. In mild cognitive impairment (MCI), small benefits from cognitive training were observed for memory functions
but there appears to be great variability in the response to treatment. Our study aimed to improve the characterization and
selection of those participants who will benefit from cognitive intervention. We evaluated the predictive value of disease-
specific biological factors for the outcome after cognitive training in MCI (n = 25) and also considered motivation of the
participants. We compared the results of the cognitive intervention group with two independent control groups of MCI patients
(local memory clinic, n = 20; ADNI cohort, n = 302). The primary outcome measure was episodic memory as measured by
verbal delayed recall of a 10-word list. Episodic memory remained stable after treatment and slightly increased 6 months after
the intervention. In contrast, in MCI patients who did not receive an intervention, episodic memory significantly decreased
during the same time interval. A larger left entorhinal cortex predicted more improvement in episodic memory after treatment
and so did higher levels of motivation. Adding disease-specific biological factors significantly improved the prediction of
training-related change compared to a model based simply on age and baseline performance. Bootstrapping with resampling
(n = 1000) verified the stability of our finding. Cognitive training might be particularly helpful in individuals with a bigger left
entorhinal cortex as individuals who did not benefit from intervention showed 17% less volume in this area. When extended to
alternative treatment options, stratification based on disease-specific biological factors is a useful step towards individualized
medicine.
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INTRODUCTION
In mild cognitive impairment (MCI), the
pre-dementia stage of Alzheimer’s disease (AD),
pharmacological treatment is ineffective, as acetyl-
cholinesterase inhibitors fail to reduce incident
dementia [1, 2] and to improve cognition [3].
∗Correspondence to: Jessica Peter, PhD, University of Old Age
Psychiatry and Psychotherapy, Bolligenstrasse 111, 3000 Bern 60,
Germany. Tel.: +49 0 31 932 89 03; E-mail: jessica.peter@puk.
unibe.ch.
Non-pharmacological therapies such as cognitive
interventions are thus gaining importance. Cog-
nitive interventions can be divided into cognitive
stimulation, cognitive rehabilitation, and cognitive
training [4]. Among those, cognitive training, which
focuses on guided practice on a set of tasks that
reflect particular cognitive functions, is beneficial in
MCI [5, 6]. Cognitive training can be divided into
strategy training (i.e., the instruction and practice
of mnemonic approaches such as the method
of loci or visual imagery) and repetitive, often
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computer-based, cognitive exercises [7]. Cognitive
exercises tend to benefit the specific training task
or domain (but see Noack et al. [8]), while strategy
training enhances cognitive functions beyond that
[7]. Cognitive interventions are typically offered
for 5–8 weeks; longer training programs did not
consistently show better results [5].
In MCI, benefits from strategy training were
observed for verbal episodic memory (i.e., verbal
delayed recall) and the Mini-Mental Status Exami-
nation (MMSE) [6, 9]. Two studies found strategy
training to stabilize verbal delayed recall over three
or six months, respectively, despite a progressing neu-
rodegenerative disorder [10, 11]. An additional study
(n = 15) reported improved processing speed in MCI,
when combining strategy training with psychoedu-
cation; the effects were maintained after 6-months
follow-up [12] and even for up to 28 months for
the MMSE [13]. Thus, strategy training seems to be
promising in prodromal stages of AD, providing the
possibility to offer an early intervention.
However, there appears to be great variability in
the response to cognitive training among partici-
pants, although it has been rarely addressed explicitly.
The combined training study by Londos and col-
leagues [12] for example, found 47% improved, 40%
remained unchanged, while 13% worsened in pro-
cessing speed. In another study in individuals with
subjective, but not objective, memory impairment
(SMI, a population at increased risk of develop-
ing dementia; n = 19), 21% worsened after cognitive
training [14]. Most of the other studies have addressed
response variability simply by reporting treatment
effects in terms of average raw scores before and after
training or by reporting the mean change and standard
deviation, respectively.
Given that cognitive training is resource intensive,
the characterization and selection of those partici-
pants who might benefit from treatment would greatly
improve the practicability and effectiveness of those
interventions. Yet, no study has explicitly aimed to
predict the response to cognitive training in patients
with either MCI or dementia due to AD and, thus,
appropriate predictor variables for these populations
are unknown. It seems obvious that motivation of
the participants, but also social support, is a key ele-
ment for a successful cognitive training. On the other
hand, several intervention studies in healthy aging
indicate a role of biological factors. For example,
age and baseline cognitive status had an influence on
the response to cognitive training in healthy elderly
participants. Brooks et al. [15] found that older-old
(≥70 years of age) healthy participants (n = 286)
benefited more from strategy training than did
younger-old (≤70 years of age). In a study by Singer
and colleagues (n = 96), perceptual speed at baseline
was the best predictor of individual learning gains (in
an episodic memory task) after strategy training in
healthy elderly individuals [16]. In patients with MCI
(n = 28), Belleville and colleagues found younger age
to be significantly correlated with change in ver-
bal episodic memory after cognitive training [17].
However, they also included healthy elderly con-
trols (n = 17) and did not report if the correlation
was significant in both groups. Apart from that,
biological factors were only used as predictors for
the outcome after medical treatment in MCI so far.
Genetic variables (i.e., APOE) but neither volume of
the hippocampus nor the basal forebrain predicted
the response to donepezil (an acetylcholinesterase
inhibitor) among those patients [18, 19]. However,
larger left and right hippocampal volumes were pre-
dictive of less cognitive decline [18]. Concerning the
response to cognitive training, the study by Engvig in
individuals with SMI found that larger pre-training
hippocampal volume was related to better verbal
episodic memory one week after cognitive training
[14]. Besides hippocampal volume, volume loss of
the entorhinal cortex is an early indicator of patho-
logical changes due to AD [20] and a strong predictor
of prodromal AD in patients with MCI [21]. Further-
more, it is significantly correlated with delayed recall
of word lists [22]. Thus, volume of the entorhinal
cortex might serve as a biological predictor for the
outcome after cognitive training, although not tested
so far.
In the present study, we set out to evaluate the pre-
dictive value of biological factors when patients with
MCI receive a six-week, well-established mnemonic
strategy training [22]. Comparable to previous cog-
nitive interventions studies (e.g., [23]), we did not
evaluate the efficiency of that specific training but
rather focused on predicting the response to inter-
vention. Verbal episodic memory (i.e., verbal delayed
recall) was used as the primary marker of the response
to training, as it is typically [5] and effectively [6] tar-
geted by strategy training in MCI. As both volume
of the left hippocampus and the adjacent entorhi-
nal cortex as well the presence of APOE 4 alleles
are highly relevant for verbal learning [24–26], all
three served as MRI-based or gene-based biologi-
cal predictors, respectively. To study the transfer of
mnemonic strategy training from the left hippocam-
pus to the right hippocampus, we also assessed spatial
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navigation. Here, volume of right hippocampal sub-
fields were used as MRI-based biological variables
as spatial memory clearly involves the right hip-
pocampus [27, 28]. Finally, to investigate more global
cognitive changes, we also studied changes in speed
of information processing which is independent of the
hippocampal formation. For comparison to previous
cognitive training studies in MCI (e.g., [13]), we also
assessed the MMSE as a global marker of cognition
despite its relatively low sensitivity to changes in the
MCI stage [29]. Frequency of completed homework
tasks indexed motivation.
MATERIALS AND METHODS
Participants
Twenty-five patients with amnestic MCI
(73.4 ± 5.3 years of age, range: 60–82; 13 females;
13.3 ± 3.3 years of education, range: 8–20) were
included. The proportion of single-domain versus
multiple-domain amnestic MCI was 7/18. All
participants were recruited from the Center for Geri-
atric Medicine and Gerontology of the University
Medical Center Freiburg. The study was approved
by the Ethics committee of the University Medical
Center Freiburg and was conducted according to
the Declaration of Helsinki. All participants gave
written informed consent prior to testing.
Inclusion and exclusion criteria
Cognitive functioning was evaluated using the
Consortium to Establish a Registry of Alzheimer’s
disease (CERAD) neuropsychological battery [30]
with German age-, gender-, and education-adjusted
norms (http://www.memoryclinic.ch). Participants
were diagnosed with MCI if at least one cognitive
function was below 1.5 SD according to established
criteria [31, 32]. Depressive symptoms were evalu-
ated using Beck’s Depression Inventory-II [33] and
the Geriatric Depression Scale [34]. No participant
reported a history of severe neurological or psychi-
atric disease, or drug or alcohol abuse. None of the
participants was taking neuroactive drugs but low
doses of sleep promoting medication did not lead to
exclusion. We did not include patients with reported
sudden steep decline of cognitive performance, focal
neurological signs, major white matter changes (i.e.,
three points on the Fazekas scale [35]) to avoid cases
with a predominantly vascular origin of cognitive
changes.
Genetic analyses
The 2/3/4 haplotypes of the DNA samples were
analyzed by polymerase chain reaction amplification
of a 290-bp frame of exon 3 of the APOE gene and
measurement of base mutations contained in codon
112 and 158 by dideoxy sequencing. The presence of
APOE 4 alleles (0, 1, or 2; coded as dummy vari-
ables) served in the prediction model detailed below.
Study procedure
At pre-training, all participants underwent base-
line neuropsychological testing. Around 3-4 months
after this baseline assessment (3.1 ± 1.5; range 1–5
months), they received a six-week cognitive interven-
tion (Fig. 1). Note that another neuropsychological
assessment immediately before the intervention was
avoided, to reduce the effects of training and habitu-
ation concerning the administered tasks. Participants
underwent post-training neuropsychological assess-
ment approximately one week (±2 days) after
completion of the training (6.2 ± 2.8 months after
baseline; range 4–9 months). A final follow-up
assessment was carried out after another interval of
6 months (Fig. 1). To reduce practice effects, an
in-house parallel version of the CERAD wordlist
was used in the assessment immediately after cog-
nitive training, while at the final follow-up the initial
wordlist was used again. Verbal delayed recall scores
of the CERAD wordlist were used as a primary
outcome measure of episodic memory. For speed
of information processing, the Trail Making Test A
(TMT-A, which is part of the CERAD) was used.
Route Learning Task (RLT)
To test navigation in a realistic scenario, we
adapted a RLT which has been used in a previ-
ous study [36]. We did not use spatial memory
from the CERAD two-dimensional spatial task (i.e.,
figure drawing and recall) as it is less prone to
AD-related spatial impairment compared to real,
three-dimensional navigation tasks [36]. The partic-
ipants were taken on a route through the basement
of the University Medical Centre Freiburg with only
limited view of the outside environment (to inner
courtyards). The route consisted of nine turns; all par-
ticipants were tested in a wheelchair to account for
differences in mobility. Although some of the partici-
pants had visited the clinic before, none had traversed
the particular hallways of the test route.
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Fig. 1. Schematic of study procedure for patients with mild cognitive impairment receiving 6 weekly sessions of cognitive intervention and
neuropsychological assessment at pre-training, post-training and follow-up. CERAD, Consortium to Establish a Registry of Alzheimer’s
disease; MMSE, Mini-Mental Status Examination.
Before testing, the participants were asked to pay
attention to the route as they would be asked to repeat
it themselves thereafter. After following the route
once, the participants sat in the wheelchair again and
at each corner of the route, they had to indicate direc-
tions to repeat the route forward (either verbally or
by pointing). The experimenter noted each error and
took the correct turn instead. After the cognitive inter-
vention (i.e., at post-training), a parallel version of
the initial RLT was done. At the final follow-up (12
months after baseline), the initial version of the RLT
was used again.
Cognitive intervention
We offered a mnemonic strategy training in groups
of 5-6 patients in six weekly sessions of 1.5 h each.
Two out of three psychologists (JP, VL, LK), blinded
to pre-training results, moderated the cognitive train-
ing using standardized documentation that adopted
an well-established protocol [22]. In brief, the inter-
vention consisted of psycho-educational information
(1/2 session), of different mnemonics and strategies,
including interactive imagery and face-name associa-
tions, to promote encoding and retrieval (5 sessions),
and of mindfulness training plus information on the
transfer of the strategies into daily life (1/2 session)
(see Supplementary Table 1 for more information).
Each strategy was introduced and practiced through-
out the session. Between the sessions, the participants
were given homework to exercise the strategies (9
homework tasks in total). Frequency of attendance
and frequency of completed homework tasks were
noted.
Comparable to a similar cognitive intervention
study in MCI [23], we did not include an active con-
trol group, as the aim of the study was the prediction
of the individual response rather than evaluating the
effectiveness of the training per se. To quantify the
effect of the intervention (without aiming to separate
effects of the specific content from those resulting
non-specifically from weekly meetings), we com-
pared the results of our study to patients with MCI
from both the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) database1 (n = 302; Table 1) and
the local memory clinic (n = 20; Table 1). Both con-
trol samples did not receive cognitive intervention.
As the very unequal sample sizes affected the homo-
geneity of variance assumption (e.g., F(2,344) = 7.31,
p < 0.001 for verbal delayed recall), only data of the
local memory clinic were statistically compared to
the intervention group (see below), while data from
ADNI are reported descriptively.
1Data used in the preparation of this article were in part obtained
from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
database (adni.loni.usc.edu). The ADNI was launched in 2003 as
a public-private partnership, led by Principal Investigator Michael
W. Weiner, MD. The primary goal of ADNI has been to test
whether serial magnetic resonance imaging (MRI), positron emis-
sion tomography (PET), other biological markers, and clinical
and neuropsychological assessment can be combined to mea-
sure the progression of mild cognitive impairment (MCI) and
early Alzheimer’s disease (AD). For up-to-date information, see
www.adni-info.org.
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Table 1
Subject characterization for the cognitive intervention group, the ADNI study, and data from the local memory clinic. The latter two groups
did not receive a cognitive intervention. Please note that in the cognitive intervention group ‘time to first follow-up’ represents the time
between pre- to post-testing
Cognitive intervention ADNI* Local memory clinic p-value
Mean SD Mean SD Mean SD
n (M/F) 25 (14/11) 302 (190/112) 20 (10/10)
Age (y) 72.9 5.1 74.1 7.1 72.9 6.1 0.99
Education (y) 13.6 3.2 15.7 3.0 12.0 3.9 0.13
Time to first follow-up (mo) 6.2 2.8 6.0 / 7.5 3.1 0.18
Time to second follow-up (mo) 11.2 2.9 12.0 / 14.2 5.2 0.01
MMSE (baseline) 25.5 2.2 27.0 1.8 25.3 2.2 0.77
Verbal delayed recall (baseline) 3.5 1.6 2.7 3.2 3.3 1.7 0.65
ADNI, Alzheimer’s disease Neuroimaging Initiative; SD, standard deviation; MMSE, Mini-Mental Status Examination. *Sociodemographic
variables were only compared between the local memory group and the cognitive intervention group.
Magnetic resonance imaging
Structural MRI was acquired at baseline (i.e.,
pre-training) using a three-dimensional Magneti-
zation Prepared Rapid Acquisition Gradient Echo
(MPRAGE) sequence and a 12-channel standard head
coil in a 3 T scanner (Tim Trio; Siemens, Erlan-
gen, Germany). The parameters applied were as
follows: flip angle of 12◦, repetition time (TR) of
2200 ms, echo time (TE) of 2.15 s, matrix size of
256 × 256 × 176, and slice thickness of 1 mm.
Hippocampal and entorhinal cortex volumetry
Structural MRI was automatically processed using
FreeSurfer 5.3 [37] to obtain gray matter volumes of
the left and right entorhinal cortices. Volumes of the
left and right hippocampi and the respective subfields
were automatically segmented using FreeSurfer 6.0
dev [38] (http://surfer.nmr.mgh.harvard.edu), as it
uses a second modality and was assumed to produce
more accurate estimates of hippocampal subfield
volumes [39]. FreeSurfer segmentations were qual-
itatively checked by two raters and compared to
an anatomical atlas. An agreement between raters
was sought on all cases with low segmentation
quality.
Normalized entorhinal cortex and hippocampal
volumes (and the respective subfields) were calcu-
lated for each individual, using residuals from a linear
regression between volume of the respective region
(y) and total intracranial volume (x) as described by
Jack et al. [40].
Statistical analyses
Statistical analyses were performed using SPSS
(version 21.0; IBM Inc.; Armonk, USA), parametric
tests (Shapiro-Wilk’s tests did not indicate that the
assumption of normality was violated), and a p-value
below 0.05 (uncorrected for multiple comparisons)
for statistical significance.
Cognitive change after intervention
A repeated measures ANOVA was used to test for
significant differences between pre- and post-training
in verbal delayed recall of the CERAD wordlist,
global cognition (MMSE), and speed of information
processing, using group as between-subjects factor
and time as within-subject factor (i.e., pre-training,
post-training and follow-up for the cognitive inter-
vention group or baseline, 6-months and 12-months
follow-up for the no-intervention group).
A repeated measures ANOVA was also used for
spatial navigation with time as within-subject factor.
Note that we were not able to compare performance
in this task to the local no-intervention group (and to
the ADNI control sample) as the here applied RLT
task was not included in either neuropsychological
assessment.
Predicting response to cognitive training
For an actual implementation in the clinical rou-
tine, we first predicted the response to cognitive train-
ing simply based on age and cognitive performance at
baseline (i.e., simple model). Subsequently, we quan-
tified the improvement of predictive accuracy when
adding MRI-based biological variables (e.g., hip-
pocampal volume), gene-based biological variables
(i.e., APOE), and motivation as additional regressors.
Response predictions were tested using step-
wise linear regressions (probability of F for entry:
p≤ 0.05, probability of F for removal: p≥ 0.10)
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and the change between pre- and post-training as
dependent variables. In stepwise linear regression,
independent variables are included one at a time in
successive order of incremental predictive value (i.e.,
the predictor explaining the most variance is entered
first). For verbal delayed recall, volume of the left
hippocampus and the left entorhinal cortex were used
as independent variables. The analysis was restricted
to the left hemisphere, where verbal information is
primarily processed [24, 25]. For spatial navigation,
which is primarily processed in the right hemisphere,
volume of the right hippocampal tail (i.e., the poste-
rior hippocampus) and the right pre-subiculum [27]
were used as independent variables. For the MMSE,
volumes of either left or right hippocampus [41]
and left or right entorhinal cortex [42] were used as
independent variables (i.e., one linear regression was
computed for the left- and another one for the right
hemisphere). In case of a significant prediction of ver-
bal delayed recall (or the MMSE, respectively) from
volume of the (whole) hippocampus, further associ-
ations were computed with its’ subfields. As speed
of information processing is usually not improved
by strategy training (although cognitive exercises
can be somewhat beneficial [5]), we did not predict
change between pre- and post-training for this vari-
able. Presence of APOE 4 alleles and frequency
of completed homework task were included in all
regression analyses. As a high number of participants
(88%) attended the complete cognitive intervention,
we did not include frequency of attendance in the
prediction models.
RESULTS
Data were available from 21 participants directly
at post-training and from 19 participants 6-months
later (Table 2). Attendance rates were high: 88% of
the participants completed all training sessions, the
remaining participants completed five (n = 2) or four
(n = 1) sessions, respectively. On average, 6.5 (out of
9) homework tasks were completed (SD 2.1). Figure 2
depicts the variability within the response to cogni-
tive training. Three patients with MCI were APOE 4
homozygotes, 12 were APOE 4 heterozygotes and
10 had no APOE 4 allele.
Cognitive change after intervention
We found a significant interaction between
group (intervention versus no-intervention) and time
(F(2,72) = 3.82, p < 0.05) for verbal delayed recall.
Patients with MCI in the cognitive training group
slightly increased their verbal delayed recall over
time, while patients with MCI from the local memory
clinic, who did not receive cognitive interven-
tion, significantly declined during the same time
interval (Fig. 3). We also found a significant inter-
action between group and time for the MMSE
(F(2,72) = 8.39, p < 0.001). Patients with MCI in the
cognitive training group increased their MMSE
scores, while those from the local memory clinic
decreased during the same time interval (Fig. 3). For
the TMT-A, we did not find a significant interac-
tion between group and time (F(2,72) = 0.07, p = 0.93).
Both patients with MCI in the cognitive training
group and in the external comparison group required
almost the same time to complete the TMT-A as com-
pared to baseline (Supplementary Figure 1). Spatial
navigation significantly improved after the cognitive
intervention (F(1,36) = 8.56, p < 0.001) (Fig. 4). We
did not find any significant difference between MCI
subtypes regarding change in verbal delayed recall,
global cognition, spatial navigation, or speed of infor-
mation processing (all p > 0.3).
Predicting response to cognitive training
Results of stepwise linear regressions are detailed
in Table 3. The simple model, representing the
Table 2
Pre- and post-training scores for the cognitive intervention group
pre-training post-training 6-months follow-up
(n = 25) (n = 21) (n = 19)
Mean SD Mean SD Mean SD
MMSE (0–30) 25.5 2.2 26.4 1.7 27.1 2.1
Verbal delayed recall (0–10) 3.5 1.6 3.6 2.5 3.7 1.9
Route learning task errors (0–9) 2.4 1.4 1.0 0.9 1.6 1.3
Processing speed (0–180 s) 52.4 19.4 47.1 18.3 51.5 15.9
Depressive symptoms (0–63) 9.6 6.6 9.4 6.9 8.8 4.8
SD, standard deviation; MMSE, Mini-Mental Status Examination; depressive symptoms were assessed with the Beck’s Depression
Inventory II.
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Fig. 2. Variability in the response to cognitive training for the Mini-Mental Status Examination (MMSE), verbal delayed recall, spatial
navigation, and processing speed in patients with mild cognitive impairment. Negative scores (red color) indicate decline from pre- to
post-training, while positive scores (green color) depict an improvement. Note: For the TMT-A and spatial navigation, scores were recoded
such that positive scores indicate an improvement, too.
clinical setting, yielded no significant result in pre-
dicting the increase in verbal delayed recall (i.e.,
neither age nor baseline performance explained
a significant proportion of the improvement after
training). When adding the MRI-based biological
variables, the gene-based biological variables, and
motivation as additional regressors, verbal delayed
recall improvement was significantly predicted by
volume of the left entorhinal cortex and frequency
of completed homework, with more volume and
more frequently completed homework being associ-
ated with greater increase in verbal delayed recall
(Table 3, Fig. 5). Left hippocampal volume, age, and
baseline performance did not explain significantly
more variance in the prediction model (Supplemen-
tary Table 2; see also Supplementary Table 4 for a
correlation matrix).
For the increase in spatial navigation and the
MMSE, only baseline performance was a significant
predictor in both the simple model (Supplementary
Table 3) and the full model (Table 3).
The presence of one or two APOE alleles was no
significant predictor of any of the cognitive change
variables (Supplementary Tables) and frequency of
completed homework tasks only predicted change in
verbal delayed recall (Supplementary Table 2).
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Fig. 3. Change in verbal delayed recall and Mini-Mental Status Examination (MMSE) between pre- to post-training and 6 months later.
The cognitive intervention group is shown in red, the ADNI and local memory clinic are depicted in blue (the latter two did not receive a
cognitive training). Significant at *p < 0.05 or ***p < 0.001, respectively. Error bars indicate ± 1 standard error of the mean. Note: Data from
the ADNI was not included in the statistical analysis.
Fig. 4. Change in spatial navigation (route learning task) between
pre- to post-training and 6 months later. Significant at *p < 0.05 or
***p < 0.001, respectively. Error bars indicate ± 1 standard error
of the mean.
DISCUSSION
The aim of this study was to analyze the pre-
dictive value of MRI- and gene-based biological
factors when patients with MCI receive a six-week
mnemonic strategy training. Rather than comparing
an intervention group against a control condition, our
aim was to identify markers that differentiate those
who benefit from cognitive intervention from those
who do not. For the outcome after training, we exam-
ined verbal delayed recall as a primary target and the
MMSE, spatial navigation, and speed of information
processing to study near and far transfer effects. We
also measured longitudinal effects of the intervention,
as these are clinically relevant.
After strategy training (and at follow-up, too), we
found a slight improvement in verbal delayed recall
scores and an increase in the MMSE, while patients
with MCI who did not receive cognitive training sig-
nificantly declined in both tasks (Fig. 3). It is unlikely
that the increase in cognitive performance in the inter-
vention group is due to the repeated completion of
the cognitive tests (i.e., re-test effect), as the sample
of patients with MCI from the local memory clinic
(and the ADNI study) decreased in both tasks, when
tested at the same time intervals with identical (or
comparable) cognitive tests. Although we did not
include an active control group that would have linked
the increase in cognition specifically to mnemonic
Table 3
Results of stepwise linear regressions with change after cognitive intervention as outcome variables, different brain areas,
frequency of completed homework tasks, age, and baseline performance as predictors
Change between pre- and post-training predictor variable r²  p
Verbal delayed recall left entorhinal cortex volume 0.52 0.47 0.01
frequency of completed homework 0.44 0.02
Mini Mental Status Examination baseline performance 0.69 –0.84 <0.001
Spatial navigation (route learning) baseline performance 0.49 –0.72 0.001
Note: Only significant results are depicted.
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Fig. 5. Relationship between change in verbal delayed recall after
cognitive training (i.e., pre- to post-intervention) and volume of
the left entorhinal cortex. Positive scores on the y-axis indicate
improvement. Significant at *p < 0.05.
strategy training, our results support previous find-
ings of strategy training to lead to a stabilization of
verbal delayed recall despite a progressing neurode-
generative disorder [10, 11].
We did not find any effect of the cognitive interven-
tion on processing speed, as performance remained
comparable to the two external data sets (Supplemen-
tary Figure 1). Finally, we found a highly significant
improvement in the RLT after the cognitive interven-
tion (Fig. 4). Although the use of alternative routes
makes simple re-tests effects less likely, we cannot
exclude habituation effects. The RLT may be partic-
ularly prone to such effects, as being chauffeured in a
wheelchair may need adaption to this unfamiliar sit-
uation. Alternatively, cognitive training may indeed
generalize across both hippocampi, or, more gener-
ally, the knowledge of the possibility to use a strategy
for episodic memory enhancement can lead to the use
of similar strategies during other learning-dependent
tasks.
For the prediction of the trainings response with
MRI- and gene-based biological factors, we found
that patients with larger left entorhinal cortex volume
improved significantly more in verbal delayed recall
after cognitive training (Fig. 6). On the contrary,
disease-specific biological factors did not signifi-
cantly improve the predictive accuracy for the RLT
and the MMSE. This is most likely explained by ceil-
ing effects and the low sensitivity of the MMSE in
the MCI stage [29]. The interpretation is supported
by a visual display of the data showing that only
those individuals with initially lower scores improved
after the cognitive intervention (Supplementary Fig-
ure 2). For verbal delayed recall, a test without ceiling
in the elderly population, we found a significantly
positive relationship between volume of the entorhi-
nal cortex and the increase in verbal delayed recall.
We found no such relationship with volume of the
left hippocampus reported previously for individuals
with SMI [14]. Different segmentation and parcella-
tion algorithms (FreeSurfer 5.3 versus 6.0, different
imaging data (T1 versus T1 and FLAIR), and differ-
ent population criteria may contribute to the disparate
findings. For both SMI and MCI, the entorhinal cor-
tex deteriorates more heavily than the hippocampus
(volume reduction entorhinal cortex 18% in SMI and
26% in MCI; volume reduction hippocampus 6% in
SMI and 16% in MCI; [43, 44]). Thus it seems that the
entorhinal cortex is an important area for both groups
although in patients with MCI it might deteriorate
more rapidly than in individuals with SMI. Regard-
ing the discrepancy between our findings and that
of Engvig et al. [14], we note that these authors did
not include entorhinal cortex volume in their analysis
which makes a direct comparison difficult. However,
in a more recent paper of this group [45] they showed
that grey matter volume of the left entorhinal cortex
increased similarly after cognitive training for both
healthy controls and patients with SMI while no such
effect was found for the hippocampus. Thus, there
seems to be an association between cognitive inter-
vention and the entorhinal cortex in both SMI and
MCI. Hence, both areas might differentially shrink
over the course of AD but in a similar way in both
SMI and MCI.
Motivation of the participants (as indexed by fre-
quency of completed homework tasks) was also
a significant predictor of improvement in verbal
delayed recall. In cognitive behavioral therapy, home-
work non-compliance is one of the top most reason
for therapy failure and there is a strong association
between patients’ motivation and homework com-
pletion as well as between homework completion
and drop-out rate or therapy outcome [47]. Inter-
estingly, when examining the number of completed
homework tasks for drop-outs and completers of the
intervention, we found that those who did not com-
plete the intervention far less often completed their
homework tasks (drop-outs: 3.7 ± 2.6; completers:
7.8 ± 1.7; t(23) = 4.65, p < 0.001), which remained
significant when controlling for attendance rates
(F(2,22) = 4.49; p < 0.05). Therefore, we believe that
homework should be an essential part of cognitive
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Fig. 6. Explained variance for the prediction of verbal delayed recall change after cognitive training (i.e., pre- to post-intervention). Significant
predictors are depicted in different shades of red, while grey color indicates a non-significant predictor. Please note that some non-significant
predictors are invisible due to a very small amount of explained variance.
interventions. Future studies might include question-
naires on motivation (and perhaps personality traits)
in order to replicate our results and to investigate the
underlying cause of this relationship. It could well
be that motivation reflects personality traits; on the
other hand, external factors such as effort, amount
of time consumed, or understanding the purpose of
the homework might also play a role. The fact that
motivation did not significantly explain performance
changes in the MMSE and the RLT is explained
again by ceiling effects in those tasks. Importantly,
age was no significant predictor for intervention-
related changes in verbal delayed recall. This finding
is contrary to a previous study by Belleville et al.
who found younger age and more years of educa-
tion to be significantly correlated with an increase
in episodic memory after memory training. We did
neither find such a correlation for age nor education
in our study (p > 0.4). However, we believe the study
by Belleville and colleagues is not directly compa-
rable to our study. Most importantly, they included
both healthy controls and patients with MCI and
they did not report if the correlations were signifi-
cant in both groups. Second, their intervention group
was younger (62.3 ± 7.3) than our intervention group
(age: 73.4 ± 5.3). Third, their patients with MCI
had a very high MMSE score (28.9 ± 1.2)—which
was very similar to that of their healthy controls
(29.0 ± 0.8)—while in our study the mean MMSE
score was 25.5 (±2.2). Besides age, baseline perfor-
mance did also not significantly predict the change
in verbal delayed recall, demonstrating the clinical
usefulness of biological, disease-specific predictor
variables (Fig. 6). In practice, cognitive training
should be recommended particularly to individu-
als with a bigger entorhinal cortex as individuals
who did not benefit from the intervention showed
a 17% smaller entorhinal cortex volume compared
to those who increased their verbal delayed recall
scores (no improvement: 1675 ± 429 mm³; improve-
ment: 2011 ± 498 mm³). This difference is significant
at p < 0.05. A post-hoc ROC analysis also revealed a
significant result (area under the curve = 0.76 [95%
CI, 0.53 – 0.98], p < 0.05) and an optimal cut-off
derived from the ROC analysis at 1659.7 mm³ with a
sensitivity and specificity of 0.7.
Limitation
The results of our study might be limited by the
relatively small sample size (n = 25) although other
cognitive intervention studies recruited even fewer
participants (n < 20, e.g., [12, 14]). When using a
bootstrapping technique [46] to evaluate the stabil-
ity of our key finding, the same variables became
significant in 72% (volume of the left entorhinal cor-
tex) and 85% (motivation) of all 1000 subsamples
(Supplementary Table 5). Variables that are selected
to be significant in 50% or more of the data sets are
considered to have a stable association with the out-
come [46]. Bootstrapping also reduces the likelihood
of Type I errors and increases the likelihood of out of
sample replication [46].
None of our predictors became significant when
the change between baseline and follow-up was used
as a dependent variable. We conclude that too many
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external/behavioral factors contribute to the long-
term effects.
Besides absolute change between pre- and post-
training, percent change might also serve as a marker
of improvement. However, we decided to focus on
the change in the absolute number of remembered
words rather than the proportional change. In our
view, an improvement of, for example, two words
at an initially high level is no less significant in
terms of cognition than an improvement at a lower
baseline performance although we realize that the
consequences for the individual might differ.
Conclusion
In summary, we found cognitive training to sta-
bilize or even improve learning-dependent behavior.
Stratifying patients with MCI based on disease-
specific biological factors might be a useful step
towards individualized medicine, when extended to
a range of alternative treatment options.
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